ORDONEZ KATHY 4

4 · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · Filed Feb 18, 2021

Insider Transaction Report

Form 4

Period: 2021-02-16

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.PACB

ORDONEZ KATHY

Director

Transactions

Exercise/Conversion
Common Stock
2021-02-16$6.98/sh+35,000$244,300→ 91,767 total
Exercise/Conversion
Common Stock
2021-02-16$5.79/sh+25,000$144,750→ 116,767 total
Exercise/Conversion
Common Stock
2021-02-16$8.98/sh+25,000$224,500→ 141,767 total
Exercise/Conversion
Common Stock
2021-02-16$3.81/sh+25,000$95,250→ 166,767 total
Exercise/Conversion
Common Stock
2021-02-16$2.90/sh+25,485$73,907→ 192,252 total
Exercise/Conversion
Common Stock
2021-02-16$2.63/sh+50,394$132,536→ 242,646 total
Sale
Common Stock
2021-02-16$47.58/sh−118,667$5,646,651→ 123,979 total
Sale
Common Stock
2021-02-16$48.47/sh−101,004$4,895,260→ 22,975 total
Exercise/Conversion
Stock Option (right to buy)
2021-02-16−35,000→ 0 total
Exercise: $6.98Exp: 2024-12-17→ Common Stock (35,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-02-16−25,000→ 0 total
Exercise: $3.81Exp: 2027-05-24→ Common Stock (25,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-02-16−50,394→ 37,106 total
Exercise: $2.63From: 2018-03-15Exp: 2028-03-15→ Common Stock (50,394 underlying)
Sale
Common Stock
2021-02-16$49.00/sh−1,100$53,900→ 21,875 total
Exercise/Conversion
Stock Option (right to buy)
2021-02-16−25,000→ 0 total
Exercise: $5.79Exp: 2025-05-20→ Common Stock (25,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-02-16−25,000→ 0 total
Exercise: $8.98Exp: 2026-05-17→ Common Stock (25,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-02-16−25,485→ 324,515 total
Exercise: $2.90From: 2017-12-15Exp: 2027-11-15→ Common Stock (25,485 underlying)

Footnotes (4)

[F1]This sale price represents the weighted average sale price of the shares sold ranging from $47.00 to $47.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4
[F2]This sale price represents the weighted average sale price of the shares sold ranging from $48.00 to $48.98 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4
[F3]The shares subject to the option are fully vested and exercisable
[F4]The shares subject to the option vest in equal monthly installment, over a four year period

Documents

1 file

4
certent-form4.xmlPrimary
PRIMARY DOCUMENT